Takeshi Ogo

4.2k total citations · 1 hit paper
72 papers, 1.8k citations indexed

About

Takeshi Ogo is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Genetics. According to data from OpenAlex, Takeshi Ogo has authored 72 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Pulmonary and Respiratory Medicine, 40 papers in Cardiology and Cardiovascular Medicine and 11 papers in Genetics. Recurrent topics in Takeshi Ogo's work include Pulmonary Hypertension Research and Treatments (51 papers), Cardiovascular Issues in Pregnancy (16 papers) and Cardiovascular Function and Risk Factors (14 papers). Takeshi Ogo is often cited by papers focused on Pulmonary Hypertension Research and Treatments (51 papers), Cardiovascular Issues in Pregnancy (16 papers) and Cardiovascular Function and Risk Factors (14 papers). Takeshi Ogo collaborates with scholars based in Japan, United Kingdom and United States. Takeshi Ogo's co-authors include Hiromi Matsubara, Eckhard Mayer, Hossein Ardeschir Ghofrani, Michael M. Madani, Victor F. Tapson, David P. Jenkins, Marion Delcroix, Xavier Jaïs, Nick H. Kim and Akihiro Tsuji and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Journal of Neuroscience.

In The Last Decade

Takeshi Ogo

65 papers receiving 1.8k citations

Hit Papers

Chronic thromboembolic pulmonary hypertension 2018 2026 2020 2023 2018 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Takeshi Ogo Japan 20 1.4k 1.0k 359 352 153 72 1.8k
Koichiro Sugimura Japan 29 1.5k 1.1× 1.5k 1.4× 341 0.9× 326 0.9× 421 2.8× 104 2.5k
Shunsuke Tatebe Japan 21 975 0.7× 808 0.8× 214 0.6× 219 0.6× 245 1.6× 80 1.5k
Andrei Seferian France 18 1.1k 0.8× 411 0.4× 260 0.7× 68 0.2× 272 1.8× 45 1.5k
Paul G Williams South Africa 5 2.2k 1.6× 1.2k 1.1× 306 0.9× 106 0.3× 256 1.7× 12 2.6k
О. М. Моисеева Russia 17 1.5k 1.1× 1.2k 1.1× 239 0.7× 42 0.1× 345 2.3× 188 2.1k
R. James White United States 19 2.6k 1.9× 1.7k 1.7× 488 1.4× 66 0.2× 285 1.9× 63 2.9k
Nobuhiro Yaoita Japan 18 566 0.4× 439 0.4× 116 0.3× 162 0.5× 165 1.1× 38 913
Nika Skoro‐Sajer Austria 22 1.6k 1.2× 1.2k 1.1× 466 1.3× 460 1.3× 60 0.4× 52 1.8k
Miguel Ángel Gómez‐Sánchez Spain 22 1.7k 1.2× 1.5k 1.4× 344 1.0× 59 0.2× 190 1.2× 40 2.4k
F Brénot France 13 1.6k 1.2× 765 0.7× 306 0.9× 107 0.3× 165 1.1× 29 2.1k

Countries citing papers authored by Takeshi Ogo

Since Specialization
Citations

This map shows the geographic impact of Takeshi Ogo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takeshi Ogo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takeshi Ogo more than expected).

Fields of papers citing papers by Takeshi Ogo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takeshi Ogo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takeshi Ogo. The network helps show where Takeshi Ogo may publish in the future.

Co-authorship network of co-authors of Takeshi Ogo

This figure shows the co-authorship network connecting the top 25 collaborators of Takeshi Ogo. A scholar is included among the top collaborators of Takeshi Ogo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takeshi Ogo. Takeshi Ogo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ogo, Takeshi, Toshiro Shinke, Nobutaka Ikeda, et al.. (2025). Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension: A Nationwide Prospective Multicenter Registry in Japan (J-BPA). Circulation Cardiovascular Interventions. 18(12). e016172–e016172.
2.
Aoki, Tatsuo, Hiroyuki Endo, Takatoyo Kiko, et al.. (2025). Clinical impact of mean pulmonary arterial pressure after balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension. Open Heart. 12(2). e003532–e003532. 1 indexed citations
3.
Asano, Ryotaro, Makoto Okazawa, Tomohiko Ishibashi, et al.. (2025). A Novel Missense Variant of <i>ZC3H12A</i> in Pulmonary Arterial Hypertension. Circulation Reports. 7(3). 207–211.
4.
Kiko, Takatoyo, Akihiro Tsuji, Jin Ueda, Keiko Ohta‐Ogo, & Takeshi Ogo. (2025). Vasodilator-induced selective pulmonary oedema in sarcoidosis-associated pulmonary hypertension with pulmonary venous stenosis. Thorax. 80(5). 320–321.
5.
Hattori, Yorito, Tatsuya Nishii, Yuriko Nakaoku, et al.. (2025). Relationship Between RNF213 p.R4810K and Echocardiographic Findings in Patients with Cerebrovascular Diseases: A Multicenter Prospective Cohort Study. Journal of the American Heart Association. 14(3). e036333–e036333. 2 indexed citations
6.
Arita, Yoh, Ryotaro Asano, Jin Ueda, et al.. (2024). Perioperative Management of Takayasu Arteritis for Cardiac Surgery ― Review and Single-Center Experience ―. Circulation Journal. 89(12). 1849–1856.
7.
Sakao, Seiichiro, Yasuhiro Kondoh, Hideyuki Kinoshita, et al.. (2024). Efficacy, safety, and pharmacokinetics of inhaled treprostinil in Japanese patients with pulmonary hypertension associated with interstitial lung disease. Respiratory Investigation. 62(6). 980–986. 3 indexed citations
8.
Hirakawa, Kyoko, Ryotaro Asano, Jin Ueda, et al.. (2024). Calcium channel blockers in patients with pulmonary arterial hypertension receiving PAH-specific treatment. International Journal of Cardiology. 406. 132043–132043. 1 indexed citations
9.
Kuwana, Masataka, Kohtaro Abe, Hideyuki Kinoshita, et al.. (2023). Efficacy, safety, and pharmacokinetics of inhaled treprostinil in Japanese patients with pulmonary arterial hypertension. Pulmonary Circulation. 13(1). e12198–e12198. 7 indexed citations
10.
Masaki, Takeshi, Makoto Okazawa, Ryotaro Asano, et al.. (2021). Aryl hydrocarbon receptor is essential for the pathogenesis of pulmonary arterial hypertension. Proceedings of the National Academy of Sciences. 118(11). 31 indexed citations
11.
Tsuji, Akihiro, et al.. (2018). Abstract 15733: Comparison of Efficacy and Safety Between Direct Oral Anticoagulant and Warfarin in Patients With Chronic Thromboembolic Pulmonary Hypertension. Circulation. 6 indexed citations
12.
Menon, K.M.J., Patrick D. Sutphin, Sonja Bartolome, Sanjeeva P. Kalva, & Takeshi Ogo. (2018). Chronic thromboembolic pulmonary hypertension: emerging endovascular therapy. Cardiovascular Diagnosis and Therapy. 8(3). 272–278. 3 indexed citations
13.
Kim, Nick H., Marion Delcroix, Xavier Jaïs, et al.. (2018). Chronic thromboembolic pulmonary hypertension. European Respiratory Journal. 53(1). 1801915–1801915. 473 indexed citations breakdown →
14.
Ueda, Jin, Akihiro Tsuji, Takeshi Ogo, et al.. (2018). Beneficial Effect of Endovascular Treatment on Villalta Score in Japanese Patients With Chronic Iliofemoral Venous Thrombosis and Post-Thrombotic Syndrome. Circulation Journal. 82(10). 2640–2646. 5 indexed citations
15.
Madani, Michael M., Takeshi Ogo, & Gérald Simonneau. (2017). The changing landscape of chronic thromboembolic pulmonary hypertension management. European Respiratory Review. 26(146). 170105–170105. 54 indexed citations
16.
Ogo, Takeshi, Akihiro Tsuji, Shigefumi Fukui, et al.. (2016). Successful balloon pulmonary angioplasty with gadolinium contrast media for a patient with chronic thromboembolic pulmonary hypertension and iodine allergy. Respiratory Medicine Case Reports. 17. 75–82. 6 indexed citations
17.
Liu, Lu, Siew Eng Choon, A. David Burden, et al.. (2015). Activating CARD14 Mutations Are Associated with Generalized Pustular Psoriasis but Rarely Account for Familial Recurrence in Psoriasis Vulgaris. Journal of Investigative Dermatology. 135(12). 2964–2970. 77 indexed citations
18.
Ogo, Takeshi, Jun Yang, Lü Long, et al.. (2013). Inhibition of Overactive Transforming Growth Factor–β Signaling by Prostacyclin Analogs in Pulmonary Arterial Hypertension. American Journal of Respiratory Cell and Molecular Biology. 48(6). 733–741. 42 indexed citations
19.
Nasim, Talat, et al.. (2012). BMPR-II deficiency elicits pro-proliferative and anti-apoptotic responses through the activation of TGFβ-TAK1-MAPK pathways in PAH. Human Molecular Genetics. 21(11). 2548–2558. 62 indexed citations
20.
Ogo, Takeshi, et al.. (1991). Effects of interleukin 4 on stromal cell-associated bone marrow culture.. PubMed. 19(9). 899–904. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026